CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Veraxa Biotech Holding AG

VRXA
$2.73BMid Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for VRXA. That does not mean none is planned.

Get an email about VRXA's next catalysts

Track Veraxa Biotech Holding (VRXA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How VRXA's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQBiotechnologyπŸ‡ΊπŸ‡ΈNorth America
Drug Pipeline

Frequently asked questions

What is in Veraxa Biotech Holding AG's drug pipeline?β†’

CatalystAlert tracks 1 drug candidate in Veraxa Biotech Holding AG's (VRXA) pipeline across Phase 2. Its lead program is VY7523 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Veraxa Biotech Holding AG's next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Veraxa Biotech Holding AG (VRXA) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track VRXA biotech catalysts?β†’

Add VRXA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Veraxa Biotech Holding AG's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply